Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes. - Venkadakrishnan VB; Presser AG; Singh R; Booker MA; Traphagen NA; Weng K; Voss NCE; Mahadevan NR; Mizuno K; Puca L; Idahor O; Ku SY; et al. (Nature communications, 2024)